Last reviewed · How we verify
Bupivacaine Liposome Injection R preparation — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Bupivacaine Liposome Injection R preparation (Bupivacaine Liposome Injection R preparation) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bupivacaine Liposome Injection R preparation TARGET | Bupivacaine Liposome Injection R preparation | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bupivacaine Liposome Injection R preparation CI watch — RSS
- Bupivacaine Liposome Injection R preparation CI watch — Atom
- Bupivacaine Liposome Injection R preparation CI watch — JSON
- Bupivacaine Liposome Injection R preparation alone — RSS
Cite this brief
Drug Landscape (2026). Bupivacaine Liposome Injection R preparation — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-liposome-injection-r-preparation. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab